PJP Among Health Care ETFs
End-of-day Nov 18, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −2.3% | +1.4% | −0.3% | +23.6% | +25.7% | +92.2% | +66.7% | +154.1% | +801.8% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$62 of every $1,000 in PJP is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 6.17% | $617.01 | 26K | $37.2M |
| 2 | GILDGilead Sciences | Healthcare | 6.16% | $615.63 | 218K | $37.1M |
| 3 | ABBVAbbVie | Healthcare | 5.93% | $592.66 | 122K | $35.7M |
| 4 | AMGNAmgen | Healthcare | 5.56% | $555.79 | 73K | $33.5M |
| 5 | JNJJohnson & Johnson | Healthcare | 5.49% | $548.91 | 119K | $33.1M |
| 6 | PFEPfizer | Healthcare | 5.36% | $536.08 | 1.1M | $32.3M |
| 7 | MRKMerck | Healthcare | 4.93% | $493.03 | 207K | $29.7M |
| 8 | ABTAbbott Laboratories | Healthcare | 4.84% | $484.34 | 279K | $29.2M |
| 9 | VTRSViatris | Healthcare | 3.75% | $375.06 | 1.1M | $22.6M |
| 10 | AMRXAmneal Pharmaceuticals | Healthcare | 3.61% | $361.41 | 1.0M | $21.8M |
| 11 | REGNRegeneron Pharmaceuticals | Healthcare | 3.52% | $352.13 | 22K | $21.2M |
| 12 | BIIBBiogen | Healthcare | 3.48% | $348.33 | 84K | $21.0M |
| 13 | UTHRUnited Therapeutics | Healthcare | 3.45% | $345.34 | 36K | $20.8M |
| 14 | TARSTarsus Pharmaceuticals | Healthcare | 3.36% | $335.63 | 259K | $20.2M |
| 15 | PRGOPerrigo | Healthcare | 3.34% | $333.76 | 1.3M | $20.1M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 6.17% |
| 2 | GILD | Gilead Sciences | 6.16% |
| 3 | ABBV | AbbVie | 5.93% |
| 4 | AMGN | Amgen | 5.56% |
| 5 | JNJ | Johnson & Johnson | 5.49% |
| 6 | PFE | Pfizer | 5.36% |
| 7 | MRK | Merck & | 4.93% |
| 8 | ABT | Abbott Laboratories | 4.84% |
| 9 | VTRS | Viatris | 3.75% |
| 10 | AMRX | Amneal Pharmaceuticals | 3.61% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.30 |
| Jun 22, 2026 | Jun 26, 2026 | $0.27 |
| Mar 23, 2026 | Mar 27, 2026 | $0.31 |
| Dec 22, 2025 | Dec 26, 2025 | $0.25 |
| Sep 22, 2025 | Sep 26, 2025 | $0.24 |
| Jun 23, 2025 | Jun 27, 2025 | $0.27 |
| Mar 24, 2025 | Mar 28, 2025 | $0.27 |
| Dec 23, 2024 | Dec 27, 2024 | $0.22 |
| Sep 23, 2024 | Sep 27, 2024 | $0.20 |
| Jun 24, 2024 | Jun 28, 2024 | $0.21 |
| Mar 18, 2024 | Mar 22, 2024 | $0.17 |
| Dec 18, 2023 | Dec 22, 2023 | $0.19 |